There is huge downstream demand for polyhydroxyethyl methacrylate (PHEMA), but the supply of upstream raw materials is insufficient.
Polyhydroxyethyl methacrylate (PHEMA for short) is a polymer material polymerized by adding hydroxyethyl methacrylate (HEMA) as a monomer and adding other auxiliary materials. Polyhydroxyethyl methacrylate appears as a colorless, transparent and easy-flowing liquid. It is miscible with water and soluble in a variety of organic solvents. Polyhydroxyethyl methacrylate has good biocompatibility, optical properties, and water absorption properties. etc., can be used as modifiers, adhesives, analytical reagents, etc. in coatings, medical, rubber, resin, fiber, electronics, textile and other fields.
In the field of coatings, polyhydroxyethyl methacrylate can be mixed with diisocyanate, epoxy resin, melamine formaldehyde resin, etc. to form two-component coatings; in the field of electronics, as a hydrophilic polymer, polyhydroxyethyl methacrylate can be used It is used as a dehydrating agent for electron microscopes; in the medical field, polyhydroxyethyl methacrylate is mainly used as a medical polymer material in ophthalmology and dentistry. It is currently the main material for manufacturing optical mirror columns, artificial corneas, and dentures. At present, polyhydroxyethyl methacrylate is mainly used in the medical field as a medical polymer material.
According to the “2022-2026 Hydroxyethyl Methacrylate (HEMA) Industry Market In-depth Research and Investment Prospect Forecast Analysis Report》 shows that thanks to the advancement of production technology, my country’s polyhydroxyethyl methacrylate production capacity has been continuously improved. At this stage, domestic polyhydroxyethyl methacrylate supply companies include Shanghai Huayi, Dongming Changshengyuan, and Xi’an Rui Xi Biotechnology, Jiangsu Sanmu, Chizhou Fangda, etc. Compared with countries such as Europe, the United States, and Japan, my country’s polyhydroxyethyl methacrylate industry started late and has deficiencies in technology and technology. Products are mostly concentrated in the mid- to low-end fields, and the competitiveness in the high-end market is weak.
Globally, the polyhydroxyethyl methacrylate market is mainly concentrated in the United States, Germany, Japan and other regions. Among them, companies such as Germany’s Evonik, Merck, Japan’s Asahi Kasei, Japan’s Mitsubishi Chemical, and the United States’ Dow Chemical have relied on technology, quality, With advantages such as scale and brand, it occupies a major share of the global high-end polyhydroxyethyl methacrylate market.
Hydroxyethyl methacrylate is the main raw material of polyhydroxyethyl methacrylate. At present, domestic production capacity of hydroxyethyl methacrylate is mostly concentrated in Jiangsu, Shandong, Anhui and other regions, with annual output remaining at about 150,000 tons. my country’s hydroxyethyl methacrylate market is relatively concentrated, with major manufacturers including Shanghai Huayi, Dongming Changshengyuan, Jiangsu Sanmu, and Anhui Renxin. Since domestically produced hydroxyethyl methacrylate is inferior to imported products in terms of purity and performance, high-end hydroxyethyl methacrylate is still dependent on imports, which limits the development of the polyhydroxyethyl methacrylate industry to a certain extent.
Industry analysts said that as a medical polymer material, polyhydroxyethyl methacrylate is used in the production of artificial corneas, optical lens columns, The main raw material for dentures. In recent years, with the improvement of my country’s medical level, the downstream market of polyhydroxyethyl methacrylate has maintained a rapid growth trend, which is beneficial to the development of my country’s polyhydroxyethyl methacrylate industry. However, from the upstream production point of view, polymethylmethacrylate The supply of upstream raw materials for hydroxyethyl acrylate is insufficient, and the high-end market relies on imports.
微信扫一扫打赏
Chinese